Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Amplatzer Amulet Left Atrial Appendage Occluder IDE
  The goal of the Amulet IDE trial was to evaluate left atrial appendage (LAA) occlusion with the Amulet device compared with the Watchman device among patients with nonvalvular atrial fibrillation (AF).
• Partial Cardiac Denervation to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
  The goal of the pCAD-POAF trial was to determine the efficacy and safety of partial cardiac denervation to reduce the risk of postoperative atrial fibrillation (POAF) following coronary artery bypass grafting (CABG).
• Changes in Maximum Daily AF Duration, Stroke, and Mortality
  What is the association between changes in maximum daily atrial fibrillation duration (MDAFD) and stroke or mortality in patients with cardiac implantable electronic devices (CIEDs)?
• Prevalence of U.S. Overweight and Obesity, Consensus on CPR, Bleeding Risk Using NSAIDs With Anticoagulants
  In this week’s View, Dr. Eagle looks at the prevalence of overweight and obesity among children, adolescents, and adults in the U.S., with forecasts up to 2050.
• CathPCI Registry: Safety and Feasibility of IVL as a Treatment For In-Stent Restenosis
  Use of intravascular lithotripsy (IVL) for the treatment of in-stent restenosis (ISR), although off-label, may be safe and feasible, according to a study reviewing data from the ACC's CathPCI Registry published in JACC: Cardiovascular Interventions.